The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer

European Journal of Surgical Oncology

Volumn 35, Issue 12, 2009, Pages 1257-1260

  Giobuin, S Mac ^a   Kavanagh, D O ^a   Myers, E ^a   Doherty, A O ^a   Quinn, C M ^a   Crotty, T ^a   Evoy, D ^a   McDermott, E ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Breast cancer; Immunohistochemistry; Lymph node; Metastasis; Sentinel node biopsy

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; COLORING AGENTS; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 70449101973     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.04.004     Document Type: Article

References (14)

1. Donegan W.L. Tumor-related prognostic factors for breast cancer. CA Cancer Clin J 47 (1997) 28-51
2. Lin P.P., Alison D.C., Wainstock J., et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11 (1993) 1536-1544
3. Giuliano A.E. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 62 (1996) 75-76
4. Turner R.R., Giuliano A.E., Hoon D.S., et al. Pathological examination of sentinel lymph node for breast carcinoma. World J Surg 25 (2001) 798-805
5. Hansen N.W., Grube B.J., Te W., et al. Clinical significance of axillary metastases in breast cancer: how small is too small?. Proc Am Soc Clin Oncol 20 (2001) 91
6. Wilkinson E.J., Hause L.L., Hoffman R.G., et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of metastases. Pathol Annu 17 (1982) 67-91
7. Moore K.H., Thaler H.T., Tan L.K., et al. Immunohistochemically detected tumour cells in the sentinel nodes of patients with breast carcinoma. Biologic metastasis or procedural artefact?. Cancer 100 5 (2004) 929-935
8. Van der Ploeg I.M., Kroon B.B., Antonini N., et al. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol 15 4 (2008) 1025-1031
9. Dowling C.M., and Hill A.D. Sentinel lymph node biopsy in breast cancer. Surgeon 2 5 (2004) 273-276
10. Jakub J.W., DIAZ N.M., Ebert M.D., et al. Completion axillary lymph node dissection minimises the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 184 (2002) 302-306
11. Eifel A., Axelson J.A., and Costa J.A. National institute of health consensus development conference statement: adjuvant therapy for breast cancer. J Natl Cancer Inst 93 (2001) 979-989
12. Gadd M, Harris J, Taghian A, et al. Prospective study of axillary radiation without axillary dissection for breast cancer patients with a positive sentinel lymph node. Presented at the Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December 8-11, 2005, Abstract 22.
13. Hwang R.F., Gonzalez-Angulo A.M., Yi M., et al. Low locoregional failure rates in selected breast cancer patients with tumor positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110 4 (2007) 725-731
14. Tan L.K., Giri D., Hummer A.J., et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26 11 (2008) 1803-1809